We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Panacea

News List

Panacea Biotec gets license to manufacture Sputnik V vaccine at Baddi, Himachal Pradesh expresspharma
July 06, 2021
Sputnik V was registered in India under the emergency use authorisation procedure on April 12, 2021, and vaccination against COVID-19 with the Russian vaccine started on May 14, 2021.
RDIF, Panacea Biotec launch production of Sputnik V in India expresspharma
May 25, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announced the launch of production of the Russian Sputnik V vaccine against coronavirus.
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion prnasia
March 26, 2021
Chime Biologics, a China-based, world-class CDMO company, announced today that it has secured a total commitment of US$190 million investment from institutional investors, and over $100 million investment has already been closed today.
Genericisation evokes fierce debate at third edition of Vantage Point financialexpress
May 15, 2017
Panelists divided on the impact of the push for generics, many laud the intent but remain sceptical of consequences